Transcode Therapeutics, Inc.
RNAZ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829635
No open-market purchases or sales by Transcode Therapeutics, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $208.1K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Transcode Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- +2 vs. Q3 2023
- Shares held
- 643.4K
- +83.3K (+14.9%) vs. Q3 2023
- Total value
- $105.4K
- −$176.2K (−62.6%) vs. Q3 2023
- New holders
- 7
- 3 more added
- Sold out
- 5
- 1 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNAZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $208.1K |
| Q1 2026 | 8 | $265.7K |
| Q4 2025 | 6 | $26.4K |
| Q3 2025 | 8 | $155.0K |
| Q2 2025 | 9 | $237.0K |
| Q1 2025 | 19 | $1.06M |
| Q4 2024 | 5 | $33.4K |
| Q3 2024 | 10 | $185.8K |
| Q2 2024 | 15 | $263.0K |
| Q1 2024 | 7 | $284.1K |
| Q4 2023 | 13 | $105.4K |
| Q3 2023 | 11 | $281.6K |
| Q2 2023 | 5 | $476.6K |
| Q1 2023 | 11 | $88.6K |
| Q4 2022 | 18 | $222.5K |
| Q3 2022 | 13 | $2.27M |
| Q2 2022 | 13 | $2.67M |
| Q1 2022 | 13 | $3.14M |
| Q4 2021 | 16 | $5.98M |
| Q3 2021 | 17 | $7.28M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Transcode Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 281,908 | $46.5K | 0.00% | +281,908 | New |
| Renaissance Technologies LLC | 187,400 | $31.0K | 0.00% | +187,400 | New |
| Geode Capital Management, LLC | 52,232 | $8.61K | 0.00% | +52,232 | New |
| Captrust Financial Advisors | 50,000 | $8.24K | 0.00% | +50,000 | New |
| HRT Financial LP | 34,966 | $5.00K | 0.00% | +18,608+113.8% | Added |
| Susquehanna International Group, LLP | 10,995 | $1.81K | 0.00% | +10,995 | New |
| XTX Topco Ltd | 10,740 | $1.77K | 0.00% | +10,740 | New |
| UBS Group AG | 7,874 | $1.30K | 0.00% | −138,656−94.6% | Reduced |
| Tower Research Capital LLC (TRC) | 5,511 | $909 | 0.00% | +171+3.2% | Added |
| Bank of America Corp | 1,621 | $266 | 0.00% | +1,621 | New |
| Wells Fargo & Company | 155 | $26 | 0.00% | +144+1,309.1% | Added |
| First Personal Financial Services | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 22 | $0 | 0.00% | 00.0% | Unchanged |
| Sabby Management, LLC | 0 | $0 | 0.00% | −250,309−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −84,010−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −31,347−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −16,153−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |